Atea Pharmaceuticals (AVIR) Net Margin (2021)

Atea Pharmaceuticals (AVIR) has 1 years of Net Margin data on record, last reported at 60.95% in Q4 2021.

  • For Q4 2021, Net Margin changed N/A year-over-year to 60.95%; the TTM value through Sep 2022 reached 18.55%, up 303.0%, while the annual FY2021 figure was 34.49%, 5700.0% up from the prior year.
  • Net Margin reached 60.95% in Q4 2021 per AVIR's latest filing, up from 85.93% in the prior quarter.
  • Across five years, Net Margin topped out at 60.95% in Q4 2021 and bottomed at 85.93% in Q3 2021.